Welcome to Magle Life Sciences

Innovation and development of polysaccharide products for biomedical applications

A researcher looking in microscope

Degradeable Starch Microsphere

Magle strives to excel in the technical and medical development of polysaccharide products for biomedical applications.

Our core knowledge is rooted in the design and development of in-vivo Degradable Starch Microspheres (DSM).

In close liaison with our customers, we have tailored DSM products for e.g., surgical hemostasis (Arista®) and interventional embolisation (Spherex®). Another sub-type of DSM developed by Magle, is used world wide to measure amylase activity and as a forensic device.

Starch microspheres are non-toxic, non-allergenic and metabolised to glucose. Together with great formulation flexibility and long stability, DSM is an ideal material for in-vivo applications.
Learn more about the DSM technology>>

News

Medafor Recognized as One of Minneapolis’ Fastest-Growing Privat (2011-10-20)
Magle is happy to announce that our partner Medafor Inc has been recognized on the Minneapolis / St Paul Business...
Read more »
Magle forges partnership to evolve DSM for embolization therapy (2010-08-15)
Together with a partner (name not disclosed at this time), Magle is developing a new type of DSM to serve an...
Read more »
Magle expands R&D capabilities (2010-08-01)
With the growing pipeline of projects and increased collaboration with our partners, Magle is proud to announce the...
Read more »

Last updated: 26 March 2010